Click for best price
Peptic Ulcer Relief Treatment Market Size, Share 2024
The global Peptic Ulcer Relief Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Proton Pump Inhibitors Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Peptic Ulcer Relief Treatment include Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Abbott Laboratories, AstraZeneca plc., Cadila Healthcare Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd. and Yuhan Corporation, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Peptic Ulcer Relief Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptic Ulcer Relief Treatment. This report contains market size and forecasts of Peptic Ulcer Relief Treatment in global, including the following market information:
Global Peptic Ulcer Relief Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Peptic Ulcer Relief Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptic Ulcer Relief Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Peptic Ulcer Relief Treatment Market Segment Percentages, by Type, 2023 (%)
Proton Pump Inhibitors
Potassium-Competitive Acid Blockers (P-CABs)
Antacids
Others
Global Peptic Ulcer Relief Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Peptic Ulcer Relief Treatment Market Segment Percentages, by Application, 2023 (%)
Hospital
Specific Clinic
Others
Global Peptic Ulcer Relief Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Peptic Ulcer Relief Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptic Ulcer Relief Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Peptic Ulcer Relief Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Daewoong Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited
Pfizer Inc.
Abbott Laboratories
AstraZeneca plc.
Cadila Healthcare Ltd.
Boehringer Ingelheim GmbH
Eisai Co. Ltd.
Yuhan Corporation
GlaxoSmithKline plc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptic Ulcer Relief Treatment, market overview.
Chapter 2: Global Peptic Ulcer Relief Treatment market size in revenue.
Chapter 3: Detailed analysis of Peptic Ulcer Relief Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptic Ulcer Relief Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Peptic Ulcer Relief Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peptic Ulcer Relief Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptic Ulcer Relief Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptic Ulcer Relief Treatment Overall Market Size
2.1 Global Peptic Ulcer Relief Treatment Market Size: 2023 VS 2030
2.2 Global Peptic Ulcer Relief Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptic Ulcer Relief Treatment Players in Global Market
3.2 Top Global Peptic Ulcer Relief Treatment Companies Ranked by Revenue
3.3 Global Peptic Ulcer Relief Treatment Revenue by Companies
3.4 Top 3 and Top 5 Peptic Ulcer Relief Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Peptic Ulcer Relief Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptic Ulcer Relief Treatment Players in Global Market
3.6.1 List of Global Tier 1 Peptic Ulcer Relief Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptic Ulcer Relief Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptic Ulcer Relief Treatment Market Size Markets, 2023 & 2030
4.1.2 Proton Pump Inhibitors
4.1.3 Potassium-Competitive Acid Blockers (P-CABs)
4.1.4 Antacids
4.1.5 Others
4.2 By Type - Global Peptic Ulcer Relief Treatment Revenue & Forecasts
4.2.1 By Type - Global Peptic Ulcer Relief Treatment Revenue, 2019-2024
4.2.2 By Type - Global Peptic Ulcer Relief Treatment Revenue, 2025-2030
4.2.3 By Type - Global Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptic Ulcer Relief Treatment Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Specific Clinic
5.1.4 Others
5.2 By Application - Global Peptic Ulcer Relief Treatment Revenue & Forecasts
5.2.1 By Application - Global Peptic Ulcer Relief Treatment Revenue, 2019-2024
5.2.2 By Application - Global Peptic Ulcer Relief Treatment Revenue, 2025-2030
5.2.3 By Application - Global Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Peptic Ulcer Relief Treatment Market Size, 2023 & 2030
6.2 By Region - Global Peptic Ulcer Relief Treatment Revenue & Forecasts
6.2.1 By Region - Global Peptic Ulcer Relief Treatment Revenue, 2019-2024
6.2.2 By Region - Global Peptic Ulcer Relief Treatment Revenue, 2025-2030
6.2.3 By Region - Global Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Peptic Ulcer Relief Treatment Revenue, 2019-2030
6.3.2 US Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.3.3 Canada Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.3.4 Mexico Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Peptic Ulcer Relief Treatment Revenue, 2019-2030
6.4.2 Germany Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.4.3 France Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.4.4 U.K. Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.4.5 Italy Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.4.6 Russia Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.4.8 Benelux Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Peptic Ulcer Relief Treatment Revenue, 2019-2030
6.5.2 China Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.5.3 Japan Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.5.4 South Korea Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.5.6 India Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Peptic Ulcer Relief Treatment Revenue, 2019-2030
6.6.2 Brazil Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.6.3 Argentina Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptic Ulcer Relief Treatment Revenue, 2019-2030
6.7.2 Turkey Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.7.3 Israel Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Peptic Ulcer Relief Treatment Market Size, 2019-2030
6.7.5 UAE Peptic Ulcer Relief Treatment Market Size, 2019-2030
7 Peptic Ulcer Relief Treatment Companies Profiles
7.1 Daewoong Pharmaceutical Co., Ltd.
7.1.1 Daewoong Pharmaceutical Co., Ltd. Company Summary
7.1.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
7.1.3 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcer Relief Treatment Major Product Offerings
7.1.4 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.1.5 Daewoong Pharmaceutical Co., Ltd. Key News & Latest Developments
7.2 Takeda Pharmaceutical Company Limited
7.2.1 Takeda Pharmaceutical Company Limited Company Summary
7.2.2 Takeda Pharmaceutical Company Limited Business Overview
7.2.3 Takeda Pharmaceutical Company Limited Peptic Ulcer Relief Treatment Major Product Offerings
7.2.4 Takeda Pharmaceutical Company Limited Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.2.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Peptic Ulcer Relief Treatment Major Product Offerings
7.3.4 Pfizer Inc. Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Peptic Ulcer Relief Treatment Major Product Offerings
7.4.4 Abbott Laboratories Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 AstraZeneca plc.
7.5.1 AstraZeneca plc. Company Summary
7.5.2 AstraZeneca plc. Business Overview
7.5.3 AstraZeneca plc. Peptic Ulcer Relief Treatment Major Product Offerings
7.5.4 AstraZeneca plc. Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.5.5 AstraZeneca plc. Key News & Latest Developments
7.6 Cadila Healthcare Ltd.
7.6.1 Cadila Healthcare Ltd. Company Summary
7.6.2 Cadila Healthcare Ltd. Business Overview
7.6.3 Cadila Healthcare Ltd. Peptic Ulcer Relief Treatment Major Product Offerings
7.6.4 Cadila Healthcare Ltd. Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.6.5 Cadila Healthcare Ltd. Key News & Latest Developments
7.7 Boehringer Ingelheim GmbH
7.7.1 Boehringer Ingelheim GmbH Company Summary
7.7.2 Boehringer Ingelheim GmbH Business Overview
7.7.3 Boehringer Ingelheim GmbH Peptic Ulcer Relief Treatment Major Product Offerings
7.7.4 Boehringer Ingelheim GmbH Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.7.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.8 Eisai Co. Ltd.
7.8.1 Eisai Co. Ltd. Company Summary
7.8.2 Eisai Co. Ltd. Business Overview
7.8.3 Eisai Co. Ltd. Peptic Ulcer Relief Treatment Major Product Offerings
7.8.4 Eisai Co. Ltd. Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.8.5 Eisai Co. Ltd. Key News & Latest Developments
7.9 Yuhan Corporation
7.9.1 Yuhan Corporation Company Summary
7.9.2 Yuhan Corporation Business Overview
7.9.3 Yuhan Corporation Peptic Ulcer Relief Treatment Major Product Offerings
7.9.4 Yuhan Corporation Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.9.5 Yuhan Corporation Key News & Latest Developments
7.10 GlaxoSmithKline plc.
7.10.1 GlaxoSmithKline plc. Company Summary
7.10.2 GlaxoSmithKline plc. Business Overview
7.10.3 GlaxoSmithKline plc. Peptic Ulcer Relief Treatment Major Product Offerings
7.10.4 GlaxoSmithKline plc. Peptic Ulcer Relief Treatment Revenue in Global Market (2019-2024)
7.10.5 GlaxoSmithKline plc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peptic Ulcer Relief Treatment Market Opportunities & Trends in Global Market
Table 2. Peptic Ulcer Relief Treatment Market Drivers in Global Market
Table 3. Peptic Ulcer Relief Treatment Market Restraints in Global Market
Table 4. Key Players of Peptic Ulcer Relief Treatment in Global Market
Table 5. Top Peptic Ulcer Relief Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Peptic Ulcer Relief Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Peptic Ulcer Relief Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Peptic Ulcer Relief Treatment Product Type
Table 9. List of Global Tier 1 Peptic Ulcer Relief Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptic Ulcer Relief Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Peptic Ulcer Relief Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Peptic Ulcer Relief Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Peptic Ulcer Relief Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Peptic Ulcer Relief Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Peptic Ulcer Relief Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Peptic Ulcer Relief Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Daewoong Pharmaceutical Co., Ltd. Company Summary
Table 31. Daewoong Pharmaceutical Co., Ltd. Peptic Ulcer Relief Treatment Product Offerings
Table 32. Daewoong Pharmaceutical Co., Ltd. Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Daewoong Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 34. Takeda Pharmaceutical Company Limited Company Summary
Table 35. Takeda Pharmaceutical Company Limited Peptic Ulcer Relief Treatment Product Offerings
Table 36. Takeda Pharmaceutical Company Limited Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 38. Pfizer Inc. Company Summary
Table 39. Pfizer Inc. Peptic Ulcer Relief Treatment Product Offerings
Table 40. Pfizer Inc. Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Pfizer Inc. Key News & Latest Developments
Table 42. Abbott Laboratories Company Summary
Table 43. Abbott Laboratories Peptic Ulcer Relief Treatment Product Offerings
Table 44. Abbott Laboratories Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. AstraZeneca plc. Company Summary
Table 47. AstraZeneca plc. Peptic Ulcer Relief Treatment Product Offerings
Table 48. AstraZeneca plc. Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. AstraZeneca plc. Key News & Latest Developments
Table 50. Cadila Healthcare Ltd. Company Summary
Table 51. Cadila Healthcare Ltd. Peptic Ulcer Relief Treatment Product Offerings
Table 52. Cadila Healthcare Ltd. Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Cadila Healthcare Ltd. Key News & Latest Developments
Table 54. Boehringer Ingelheim GmbH Company Summary
Table 55. Boehringer Ingelheim GmbH Peptic Ulcer Relief Treatment Product Offerings
Table 56. Boehringer Ingelheim GmbH Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 58. Eisai Co. Ltd. Company Summary
Table 59. Eisai Co. Ltd. Peptic Ulcer Relief Treatment Product Offerings
Table 60. Eisai Co. Ltd. Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Eisai Co. Ltd. Key News & Latest Developments
Table 62. Yuhan Corporation Company Summary
Table 63. Yuhan Corporation Peptic Ulcer Relief Treatment Product Offerings
Table 64. Yuhan Corporation Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Yuhan Corporation Key News & Latest Developments
Table 66. GlaxoSmithKline plc. Company Summary
Table 67. GlaxoSmithKline plc. Peptic Ulcer Relief Treatment Product Offerings
Table 68. GlaxoSmithKline plc. Peptic Ulcer Relief Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. GlaxoSmithKline plc. Key News & Latest Developments
List of Figures
Figure 1. Peptic Ulcer Relief Treatment Segment by Type in 2023
Figure 2. Peptic Ulcer Relief Treatment Segment by Application in 2023
Figure 3. Global Peptic Ulcer Relief Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Peptic Ulcer Relief Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Peptic Ulcer Relief Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptic Ulcer Relief Treatment Revenue in 2023
Figure 8. By Type - Global Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 16. US Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 28. China Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Peptic Ulcer Relief Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Peptic Ulcer Relief Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Daewoong Pharmaceutical Co., Ltd. Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Takeda Pharmaceutical Company Limited Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Pfizer Inc. Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Abbott Laboratories Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. AstraZeneca plc. Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Cadila Healthcare Ltd. Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Boehringer Ingelheim GmbH Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Eisai Co. Ltd. Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Yuhan Corporation Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. GlaxoSmithKline plc. Peptic Ulcer Relief Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
